|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 8515 GEORGIA AVENUE, SUITE 400 |
Address2 | |
City | SILVER SPRING |
State | MD |
Zip Code | 20910-3492 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 2968-24
|
||||||||
|
6. House ID# 322330001
|
TYPE OF REPORT | 8. Year | 2014 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Michelle M. Artz, Director of Governemnt Affairs |
Date | 07/16/2014 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 933 Provisions related to the value of association meetings and the importance of Federal Employee participation in those meetings. Opposition to the Coburn Amendment S. Amdt.67.
Funding for Title VIII Nursing Workforce Programs in Function 530, 302B in the Budget process as well as the Budget Resolution.
Funding for Title VII and Title VIII Workforce programs.
Supporting funding for Title X Family Planning Programs.
Provisions related to Nurse Workforce Programs in Title VIII of the PHSA in the sequester negotiations.
Provisions related to Nursing Quality in the MILCON/VA Appropriations bill.
Provisions related to support for funding Healthcare Disparities initiatives.
Funding for Title V Maternal and Child Health Services Block Grant Program in FY 2015.
Support for continued funding for programs aimed at addressing racial and ethnic disparities and achieving health equity.
Funding for the National Health Service Corps.
Funding levels for NIOSH for FY 2015.
Report language for Labor HHS bill supporting Home Health Pilot.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jerome |
Mayer |
|
|
|
April |
Canter |
|
|
|
Elizabeth |
Heavener |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Letter to White House to reduce the coverage and misuse of antibioties in food animal production including strengthening and finalizing voluntary guidelines and moving forward with mandatory withdrawls of unsafe uses of antibiotics - and support improvements to reporting requirements for livestock antibiotics sales.
Letter to committee about chemicals in Commerce Act.
17. House(s) of Congress and Federal agencies Check if None
White House Office, Food & Drug Administration (FDA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jerome |
Mayer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Provisions related to Registered Nurse Safe Staffing.
Provisions related to Advance Practice Registered Nurses and Home Health Certification
Provisions related to Safe Patient Handling and Mobility
DME - Face-to-Face Physician Signature
Comments related to the Evaluation of the Graduate Nurse Education Demonstration Program (78 Fed. Reg. 20321).
Provisions related to the repeal of the Sustainable Growth Rate formula and reform of Medicare payment.
Support for S. 1143 - Protecting Access to Rural Therapy Service (PARTS) Act.
Support for H.R. 2180 SGR fix and Medicare Reform.
Oppose a 14 percent cut in Medicare Home Health over 4 years and decreased access to care.
Support for provisions to provide incentive payments to APRNs.
Support for H.R. 2986 - Protecting Access to Primary Care Act.
Support for the development of a calculator to help consumers understand the total costs of health insurance options.
Support for HHS to make all rate filings public.
Support for provider non-discrimination section of ACA.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jerome |
Mayer |
|
|
|
April |
Canter |
|
|
|
Elizabeth |
Heavener |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 485 National Nurse Act of 2013
Provisions related to Emergency Contraception as an over-the-counter product.
In opposition to the District of Columbia Pain-Capable Unborn Child Protection Act H.R. 1797.
S. 649; Safe Communities, Safe School Act, - support for.
Provisions related /the House Resolution to commemorate National Nurses Week (H.R. Res. 540).
Support for provisions related to BPA in Food Packaging Right to Know Act.
Strengthening provisions in S. 1009 Chemical Safety Improvement Act.
Support for a final unique device identifier rule.
Support for provisions to reauthorize funding for quality initiatives.
Support for Carol Romano, PhD, RN, BC, NEA, FAAN, FAC MI, RADM (Ret.) USPHS for the position of U.S. Surgeon General.
Support for H.R. 2457 Women's Preventive Health Awareness Campaign Act.
In opposition of House Chemicals in Commene Act Discussion Draft.
Support for S. 1944 TRICARE Moms Improvement Act,
Support for H.R. 4663. Protect patient access and promote hospital efficiency act.
Support Maternal Health Accountability Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jerome |
Mayer |
|
|
|
April |
Canter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
S. 744 Border Security, Economic Opportunity, and Immigration Modernization Act of 2013 - Support to urge protection of Health Care Needs of Children.
Support Health Immigrant Women and Families Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
April |
Canter |
|
|
|
Jerome |
Mayer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Provisions related to the Opposition to the Coal Residuals Reuse and Management Act of 2013, H.R. 2218.
The Federal and State Partnership for Environmental Protection Act of 2013 and the Reducing Excessive Deadline Obligations Act of 2013.
Strengthening lanuage to S. 1009 Chemical Safety Improvement Act/Support White House Climite Initiatives.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jerome |
Mayer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |